PhoenixBio , Ltd. Overview
PhoenixBio , Ltd. (6190.T) has a PEG ratio of -15.04, below the Healthcare sector average of 11.77.
Get informed when a big investor buys or sells
+ Follow-15.04
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for 6190.T is -15.04. That is below the Healthcare sector average of 11.77. Investors often review this figure alongside PhoenixBio , Ltd.'s historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, 6190.T currently prints -15.04 for PEG ratio, while the sector average sits near 11.77. That is roughly 227.8% below the sector mean. Large gaps often invite a closer look at PhoenixBio , Ltd.'s growth, margins, and balance sheet.
A PEG ratio of -15.04 for PhoenixBio , Ltd. is not 'good' or 'bad' on its own. Compare it with the peer average (11.77) and with 6190.T's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting 6190.T's PEG ratio (-15.04), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack PhoenixBio , Ltd.'s PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
